Sander C Ebbers

5PUBLICATIONS
5CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Pollution and contamination not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 22, 2023
Prophylactic Medication during Radioembolization in Metastatic Liver Disease: Is It Really Necessary? A Retrospective Cohort Study and Systematic Review of the Literature.

Manon N G J A Braat, Sander C Ebbers, Ahmed A Alsultan

|Jul 27, 2022
Baseline Imaging Derived Predictive Factors of Response Following [177Lu]Lu-PSMA-617 Therapy in Salvage Metastatic Castration-Resistant Prostate Cancer: A Lesion- and Patient-Based Analysis.

Esmée C A van der Sar, Adinda J S Kühr, Sander C Ebbers

|Feb 02, 2022
Inflammatory markers and long term hematotoxicity of holmium-166-radioembolization in liver-dominant metastatic neuroendocrine tumors after initial peptide receptor radionuclide therapy.

Sander C Ebbers, Tessa Brabander, Margot E T Tesselaar

|Dec 09, 2021
Gallium-68-somatostatin receptor PET/CT parameters as potential prognosticators for clinical time to progression after peptide receptor radionuclide therapy: a cohort study.

Sander C Ebbers, Muriël Heimgartner, Maarten W Barentsz

|May 22, 2020
Verification Study of Residual Activity Measurements After Yttrium-90 Radioembolization with Glass Microspheres.

S C Ebbers, B Kunnen, B J van Nierop

Pageof 1

Frequent Collaborators

3 joint publications

Arthur J A T Braat

1 joint publications

Esmée C A van der Sar

1 joint publications

Andrew M Henderson

1 joint publications

Bart de Keizer